V. F. Bui-n, C. B. , G. D. , and H. G. , -Le BNP un marqueur biologique de l'insuffisance cardiaque aiguê, 2005.

M. A. Hollander-j-e, G. D. Mccullough-p, . Nowak-r, . Green-g, . Saltzberg-m et al., -Rapid Emergency Department Heart Failure Outpatient Trial investigators. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath, J Am Coll Cardiol, vol.44, issue.6, pp.1328-1361, 2004.

E. D. Logeart, J. P. Thabut-g, C. C. Beyne-p, . Beauvais-f, . Bouvier-e et al., Annales de cardiologie et d'angéiologie-Predischarge B type natriuretic petide assay for identifying patients at High Risk of re admission after decompensated heart failure, J Am Coll Cardiol Feb, vol.5843, issue.184, pp.284-288635, 2004.

V. R. , A. N. Barro-s, C. C. , C. E. , C. V. et al., -The NT-pro- BNP assay identifies very elderly nursing home residents suffering from pre-clinical heart failure, Eur J Heart Fail, vol.7, issue.4, pp.542-51, 2005.

W. Larson-m-g, L. D. Benjamin-e-j, . Leip-e-p, . Omland-t, . Wolf-p-a et al., Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death -Prognosis of decompensated heart failure patients with preserved systolic function is predicted by ntprobnp variations during hospitalisation 21 LOGEART D .-Dosage du BNP dans l'insuffisance cardiaque.MT CardioIdentification and guided treatment of ventricular dysfunction in general practice using blood B type natriuretic peptide, N Engl J MedInternational journal of cardiologyBr J Gen Pract, vol.35058, issue.3551, pp.655-663, 2004.

V. N. , G. A. Bordenave-l, J. G. Funck-f, L. Gueffet-p, D. A. Helloco et al., n°1. 24 LEPRINCE P.-BNP versus Ntpro BNP pour le diagnostic de l'insuffisance cardiaque chez le sujet agé.Thèse med Université Paul Sabatier (Toulouse)Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study, J Am Coll Cardiol, vol.650, issue.21, pp.2097-2105, 2000.

M. , K. V. , P. J. Hassager-c, . Nielsen-h, T. J. Krogsgaard-k et al., -NT-pro-BNP a diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function, Heart. Feb, vol.89, issue.2, pp.150-154, 2003.

M. Hartman-k-a, . Grill-d-e, J. J. Burnett-j-c, and . Jaffe-a-s, Only large reductions in concentrations of natriuretic peptides are associated with improved outcomes in ambulatory patients with chronic heart failure, Clinical Chemistry, vol.55, pp.78-84, 2009.

J. Azevedo-a, . Lourenco-p, . Goncalves-f-r, . Ferreira-a, and . Bettenourt-p, -Intraindividual variation of amino-terminal pro b type natriuretic peptide levels in patients with stable heart failure, am J Cadiol, vol.98, pp.1248-1250, 2006.

J. P. Funck-f, T. B. Bellorini-m, L. J. Guillard-n, and D. , Annales de cardiologie et d'angéiologie, pp.285-289, 2003.

L. D. Saudubray-c, . Beyne-p, . Thabut-g, and C. C. Ennezat-p-v, Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea, J Am Coll Cardiol, vol.40, pp.1794-800, 2002.

B. A. , L. Van-kimmenade-r-r, . Lainchbury-j-g, . Richards-a-m, and . J. Ordonez-llanos, Effect of body mass index on diagnostic and pronostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea, Arch Intern Med, vol.167, pp.400-407, 2007.

L. A. Hengstenberg-c, L. H. Riegger-g-a, . Schunkert-h, and . Holmer-s, -Effect of compensated rénal dysfunction on approved heart failure markers : direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP, Hypertension, vol.46, pp.118-141, 2005.

A. S. , L. Baggist-a, C. A. , and K. D. Tung-r, Renal function, congestive heart failure, and amino-terminal pro-brain atriuretic peptide measurement : results from the probnp investigation of dyspnea in the emergency département (PRIDE) study, J Am Coll Cardiol, vol.47, pp.91-98, 2006.

M. J. Badskjaer and . Hansen-fs, BNP versus NT-pro BNP pour le diagnostic de l'insuffisance cardiaque chez le sujet agéValue of N-terminal proBNP in the diagnosis of left ventricular systolic dysfunction in primary care patients referred for echocardiography, pp.141-146, 2003.

M. C. Scholer-a and . K. Laule-kilian, Use of Btype natriuretic peptide in the evaluation and management of acute dyspnea, N. Eng. J. of Med, vol.12, pp.647-654, 2004.

T. Frampton-c-m, . Yandle-t-g, . Espiner-e-a, . Nicholls-m-g, and . Richards-a-m, -Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide-(N-BNP) concentrations, Lancet, vol.355, pp.1126-1156, 2000.

W. M. Hamm-c, Role of B-type natriuretic peptide (BNP) and NT-pro-BNP in clinical routine, Heart, vol.92, pp.843-852, 2006.

J. Van-kimmenade-r, L. J. Bayes-genis, . J. Ordonez-llanos, . M. Santalo-bel, . Pinto-y-m et al., -NTproBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study, Eur Heart J. Feb, vol.27, issue.3, pp.330-337, 2006.

B. P. Caffin-p-y, . Barazer-i, . Vergnes-c, L. S. Sedighian-s, . Pilossof-r et al., -Use N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea elderly patients, Am Heart J, vol.151, issue.3, pp.690-698, 2006.

B. A. Santalo-bel, . Zapico-muniz-e, C. C. Lopez-l, L. J. Bellido, and C. P. Ordonez-llanos-j, -N-terminal probrain natriuretic peptide (NtproBNP)) in the emergency diagnosis and in-hospital monitoring of patients with dyspnea and ventricular dysfunction, Eur J Heart Fail, vol.6, issue.3, pp.301-308, 2004.

A. S. , R. E. Sbragia-p, A. P. Taieb-l, . Pieri-b, and . Gelisse-r, -Accuracy of tissue Doppler echography in the emergency diagnosis of decompensated heart failure with preserved left ventricular systolic functiun: comparaison with B type natriuretic peptide measurement, Echocardiography, vol.22, issue.8, pp.657-64, 2005.

A. U. Svensson-e, -Natriuretic peptide biomarkers as information indicators in elderly patients with possible heart failure followed over six years: a head-to-head comparison of four cardiac natriuretic peptides, J Card Fail, 2007.

M. Shibata-m-c and C. , Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure ( SENIORS), Eur Heart J, vol.26, pp.215-240, 2005.

S. Française-de-cardiologie, Société Francçaise de Gériatrie et gerontology Recommandations pour le diagnostic et la prise en charge de l'insuffisance cardiaque agé, Revue de Gériatrie, vol.29, pp.577-594, 2004.

M. Mcdonagh and T. Byrne-j, Titration of vasodilatator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration : randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy, Am Heart J, vol.138, pp.1126-1158, 1999.

P. Mccullough, . Nowak-r-m, and J. Mccord, B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure: Analysis From Breathing Not Properly (BNP) Multinational Study, Circulation, vol.106, issue.4, pp.416-438, 2002.
DOI : 10.1161/01.CIR.0000025242.79963.4C

D. Christenson-r-h, Dynamic Cardiovascular risk assessment in elderly people, J Am Coll Cardiol, vol.55, pp.441-450, 2010.

Q. and K. P. Kazanegra-r, Utility of B-type natriuretic peptide (BNP) in the diagnosis of CHF in an urgent care setting, J Am Coll Cardiol, vol.37, pp.379-85, 2001.